Radiopharm Theranostics (NasdaqCM:RADX) Update / Briefing September 24, 2025 08:30 PM ET Company ParticipantsDimitris Voliotis - Chief Medical OfficerRamji Rajendran - Radiation OncologistRiccardo Canevari - MD & CEODimitris VoliotisHey. So hi, everybody. Welcome to our third Radiopharm Theranostics webinar. I am Dimitris Woliotis. I am the Radiopharm chief medical officer.And I can see that we still have people joining, so let's give it another, like, twenty seconds or so until everybody until the counter ...